| PRPFX | RLBFX | PRPFX / RLBFX | |
| Total Expense Ratio | 0.79 | 0.30 | 263% |
| Annual Report Gross Expense Ratio | 0.79 | 0.30 | 263% |
| Fund Existence | 44 years | 24 years | - |
| Gain YTD | 1.843 | 8.571 | 22% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | 1000 | N/A | - |
| Net Assets | 7.23B | 288B | 3% |
| Annual Yield % from dividends | 1.12 | 2.05 | 55% |
| Returns for 1 year | 12.92 | 11.63 | 111% |
| Returns for 3 years | 57.24 | 39.87 | 144% |
| Returns for 5 years | 56.43 | 34.02 | 166% |
| Returns for 10 years | 106.90 | 86.24 | 124% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VVIEX | 16.98 | 0.36 | +2.17% |
| VOYA VACS Index Series EM Portfolio | |||
| AIGGX | 15.51 | 0.30 | +1.97% |
| Aristotle Growth Equity I-2 | |||
| JOEAX | 17.37 | 0.16 | +0.93% |
| JOHCM Emerging Markets Opps Investor | |||
| JFNAX | 86.30 | N/A | N/A |
| Janus Henderson Global Life Sciences A | |||
| LVPSX | 103.68 | -0.17 | -0.16% |
| ProFunds Large Cap Value Svc | |||